Regeneron is a biotechnology company that develops, manufactures and commercializes medicines for a variety of diseases and conditions. It was founded in 1988 and has headquarters in Westchester County, New York. Learn the latest information and analysis on the company, REGN stock price today, stock news, how much one share costs and other information to help you make investment decisions.
Check out Gainy to see insights on stock prices and more.
Regeneron is one of the largest biotech companies by market cap and has had an annual revenue growth of 15% over the past 5 years. The company has grown rapidly and can continue to grow thanks to great management and a promising product pipeline. Regeneron has many important collaborations with other key players in the industry.
The Regeneron stock price reached its all-time high of $747 on April 7, 2022, and fell back down below its previous level and trades under $600. This may be a good entry point for biotech enthusiasts to buy a strong company that has over ten drugs in phase 3 trials.
Check back to this page for the REGN stock quote or download Gainy to see if REGN fits your portfolio and investment goals, get other stock quotes and recommendations that fit your portfolio and interests.
